Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2021-04-29 AGM Information
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 95% confidence The document is a circular related to the Annual General Meeting (AGM) of Sisram Medical Ltd. It includes details about the proposed re-election of directors, granting of general mandates to buy back and issue shares, and the notice of the AGM itself. It also contains proxy arrangements and precautionary measures for the AGM. The content is typical of materials sent to shareholders ahead of an AGM to inform them about the meeting agenda and resolutions to be voted on. It is not the AGM presentation or minutes, but rather the circular and notice for the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length is substantial (15,000 characters), indicating it is not a brief announcement but a full circular with detailed information for the AGM.
2021-04-29 English
2020 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is titled '2020 Annual Report' and includes comprehensive sections typical of an annual report: financial summary, chairman's statement, CEO review, management discussion and analysis, report of the directors, corporate governance report, biographical details of directors and senior management, independent auditor's report, consolidated financial statements, notes to the financial statements, and an Environmental, Social and Governance Report. The content covers full financial performance and company activities for the fiscal year ended December 31, 2020. The document length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2020
2021-04-29 English
CONNECTED TRANSACTION - REGISTRATION SUPPORT SERVICE AGREEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a connected transaction involving a Registration Support Service Agreement between the company and a related party. It discusses the nature of the agreement, the parties involved, the regulatory implications under the Hong Kong Listing Rules, and internal controls related to connected transactions. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal announcement of a corporate transaction subject to regulatory disclosure requirements, specifically under the Listing Rules for connected transactions. It is not a full financial report, audit report, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2021-04-23 English
DISCLOSEABLE AND CONNECTED TRANSACTION RELATING TO THE PROPOSED ACQUISITION OF SHANGHAI FOSHION MEDICAL SYSTEM CO., LTD. AND CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
Capital/Financing Update Classification · 95% confidence The document is an announcement from Sisram Medical Ltd regarding a discloseable and connected transaction related to the proposed acquisition of Shanghai Foshion Medical System Co., Ltd. It details the terms of the acquisition, the consideration, conditions to closing, reasons and benefits of the acquisition, listing rules implications, and changes in the use of proceeds from a global offering. The document is an announcement of a transaction and includes information about the upcoming extraordinary general meeting (EGM) for shareholder approval. It does not contain financial statements or detailed financial performance data itself but rather describes the transaction and related corporate actions. This fits the category of a Capital/Financing Update (CAP) as it relates to a significant acquisition and changes in use of proceeds, which are financing activities. It is not a full annual or interim report, nor a regulatory filing or proxy solicitation. Therefore, the appropriate classification is CAP with high confidence.
2021-04-22 English
VOLUNTARY ANNOUNCEMENT - Launch of Alma PrimeX
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by Sisram Medical Ltd regarding the launch of a new product platform, Alma PrimeX. It is not a financial report, regulatory filing, or any form of shareholder meeting material. The content focuses on product launch details and business strategy rather than financial results, governance, or capital changes. The document is relatively short (2892 characters) and serves as a corporate announcement about a new product, which does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. Given the nature of the content and the absence of financial or regulatory information, the best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2021-04-12 English
QUARTERLY UPDATE ANNOUNCEMENT
Regulatory Filings Classification · 95% confidence The document is titled 'QUARTERLY UPDATE ANNOUNCEMENT' and is an announcement made by the Board of Directors pursuant to listing rules. It references previous announcements related to the company's delisting stages and quarterly updates. The document length is 2796 characters, which is relatively short and primarily provides an update on the company's status, including suspension of trading and resumption proposal status. It does not contain actual financial statements or substantive financial data typical of an Interim/Quarterly Report (IR). Instead, it serves as a regulatory announcement updating the market on the company's situation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-04-08 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.